JOURNAL BROWSE
Search
Advanced SearchSearch Tips
An Empirical Study on Traditional, Complementary and Alternative Medicine Usage among Malaysian Cancer Patients
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
An Empirical Study on Traditional, Complementary and Alternative Medicine Usage among Malaysian Cancer Patients
Nagashekhara, Molugulu; Murthy, Vasudeva; Mruthyunjaya, Anil Tumkur; Ann, Lim Li;
  PDF(new window)
 Abstract
Usage of traditional, complementary and alternative medicine (TCAM) has gained popularity over the past few years. However, very little is known about TCAM use among Malaysian cancer patients. This study aimed to identify the determinants of TCAM usage among cancer patients with determination of relationships between demographic factors, patient satisfaction with conventional treatment, knowledge on TCAM and healthcare professional influence. Patient`s perceptions towards TCAM were also determined. A simple random convenient sampling method was used to recruit 354 patients from Hospital Kuala Lumpur between February to April 2013. All were directly interviewed with a structured questionnaire. In this study, 172 respondents were TCAM users. There was no significant differences between demographic background of respondents in the usage of TCAM. Minimal correlation was found between patient satisfaction with the conventional treatment and usage of TCAM (r
 Keywords
TCAM;cancer;satisfaction;knowledge;health care professionals;influence;Malaysia;
 Language
English
 Cited by
1.
Review of the Burden of Esophageal Cancer in Malaysia,;;;

Asian Pacific Journal of Cancer Prevention, 2016. vol.17. 8, pp.3705-3709 crossref(new window)
 References
1.
Arthur K, Belliard JC, Hardin SB, et al (2012). Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients. Integr Cancer Ther, 11, 232-2. crossref(new window)

2.
Alex F. Broom and Assa Doron (2013). Traditional medicines, collective negotiation, and representations of risk in indian cancer care. Qualitative Health Res, 23, 54-5. crossref(new window)

3.
Astin JA (1998). Why patients use alternative medicine: results of a national study. J Am Med Associat, 279, 1548-3. crossref(new window)

4.
Broom A, Doron A (2012). The rise of cancer in urban india: cultural understandings, structural inequalities, and the emergence of the clinic. health: an interdisciplinary journal for the social study of health, Illness Med, 16, 250-6.

5.
Cancer Fact, Figures (2012). Epidermiology surveilance. Available: http://www.cancer.org/acs/groups/content/@ epidemiologysurveilance/documents/document/ acspc-031941.pdf [accessed 2012 September 27].

6.
Chang KH, Rachel B, Choong MA, Sweeney KJ, Kerin MJ (2011). Complementary and alternative medicine use in oncology: A questionnaire survey of patients and health care professionals. BMC Cancer, 11-6

7.
Cohen SM, Arnold LL (2011). Chemical Carcinogenesis. Toxicological Sci, 120, 76-2 crossref(new window)

8.
Ernst E , White AR (2011). Prospective studies of the safety of acupuncture: a systematic review. Am J Med, 110, 481-5.

9.
Farooqui M, Hassali MA, Aishah AS (2012). Complementary and alternative (CAM) use by Malaysian oncology patients. Complement Ther Clin Pract, 18, 144-0.

10.
Hyodo I, Amano N, Eguchi K, et al (2005). Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol, 23, 2645-4.

11.
Ladas EJ, Rivas S, Ndao D, et al (2014). Use of traditional and complementary/alternative medicine (TCAM) in children with cancer in guatemala. Pediatr Blood Cancer, 61, 687-92 crossref(new window)

12.
Latest Cancer Statistics. (2012). Facts sheets. Available: http://www.who.int/mediacentre/factsheets/fs297/en/index. html[accessed 2013 October 27].

13.
Maha N, Shaw A, (2007). Academic doctors' views of complementary and alternative medicine (CAM) and its role within the NHS: an exploratory qualitative study. BMC Complement Alternative Med, 7-17

14.
Maihebureti A, Sharifa E, Syed, A (2011). Role of traditional and complementary medicine in universal coverage. Malaysian J Public Health Med, 11, 1-5

15.
Molassiotis A, Ortega PF, Pud D, et al (2005). Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol, 16, 655-3. crossref(new window)

16.
Paltiel O, Avitzour M, Peretz, T, et al (2001). Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol, 19, 2439-8

17.
Putipun P, Sutheechet N, Ratanamongkol P (2012). A survey of complementary and alternative medicine use in cancer patients treated with radiotherapy in Thailand. Evid Based Complement Alternat Med, 2012, 670408.

18.
Shih V, Chiang J, Chan A (2009). Complementary and alternative (CAM) usage in Singaporean adult cancer patients. Ann Oncol, 20,752-7. crossref(new window)

19.
Shin J, Park EC, Bae HC, et al (2015). Need to pay more attention to attendance at follow-up consultation after cancer screening in smokers and drinkers, Asian Pac J Cancer Prev, 16, 109-7. crossref(new window)

20.
Shin, JY, Kim SY, Park B, et al (2012). Predictors of complementary and alternative medicine use in cancer care: results of a nationwide multicenter survey in Korea. Evid Based Complement Alternat Med, 2012, 1-6

21.
Siti ZM, Tahir A, Farah AI, et al (2009). Use of traditional and complementary medicine in Malaysia: a baseline study. Complement Ther Med, 17, 292-9. crossref(new window)

22.
Soraya HS, Suhainan S, Nor AE, Mohd RS, Sharifah Nash (2011). The use of complementary and alternative medicine among malay breast cancer survivors. Altern Ther Health Med, 17, 50-6.

23.
Stephen JC, Andrew JM (2011). Interaction between complementary and alternative medicine with conventional anti-cancer medicine. Cancer Forum, 35, 1-5

24.
Umit Agoni et al (2015). Predictors of knowledge level and awareness towards breast cancer among turkish females, Asian Pac J Cancer Prev, 16, 275-2. crossref(new window)

25.
Wong LC, Chan E, Tay S, Lee KM, Back M (2010). Complementary and alternative medicine practices among Asian radiotherapy patients. Asia Pac J Clin Oncol, 6, 357-3. crossref(new window)

26.
Wen Y, Pan XF, Huang WZ et al (2015). Quality of life for patients with esophageal/gastric cardia precursor lesions or cancer: a one-year prospective study. Asian Pac J Cancer Prev, 16, 45-1. crossref(new window)

27.
Yu FQ, Murugiah MK, Khan AH, Mehmood T (2015). Metasynthesis exploring barriers to health seeking behaviour among Malaysian breast cancer patients, Asian Pac J Cancer Prev, 16, 145-52. crossref(new window)

28.
Zainal AO, Nor Saleha IT (2007). Malaysian Cancer Statistics - Data and Figures. Malaysia: Ministry of Health.